Rotterdam Study second cohort
Rotterdam Study, second cohort...
Description
The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in the city of Rotterdam, The Netherlands. The study aims to unravel etiology, preclinical course, natural history and potential targets for intervention for chronic dise...
General Design
- Type
- Cohort study
- Cohort type
- Population cohort
- Data collection type
- Retrospective, Prospective
- Design
- Longitudinal
- Start/End data collection
- 2000 (ongoing)
- Design paper
- Objectives, design and main findings until 2020 from the Rotterdam Study.
Population
- Countries
- Netherlands (the)
- Regions
- Rotterdam
- Number of participants
- 4472
- Number of participants with samples
- 3011
- Population age groups
- Middle-aged (45-64 years), Aged (65+ years)
Organisations
Lead organisations
- Erasmus MC (EMC)Netherlands (the)
Contributors
Subpopulations
List of subpopulations for this resource...
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Networks
Part of networks...
Publications
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study
Objectives, design and main findings until 2020 from the Rotterdam Study.
The Rotterdam Study: 2010 objectives and design update
The Rotterdam Study: 2012 objectives and design update
The Rotterdam Study: 2014 objectives and design update
The Rotterdam Study: 2016 objectives and design update
The Rotterdam Study: 2018 update on objectives, design and main results
The Rotterdam Study: objectives and design update
Access conditions
- Data access conditions
- health or medical or biomedical research
- Release type
- Continuous
- Release description
- Once a follow-up is completed and data have been processed.
- Linkage options
- no
Funding & Acknowledgements
- Funding
- The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; The Netherlands Organisation for Scientifc Research (NWO); The Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); The Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science; the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.
- Acknowledgements
- The contribution of inhabitants, general practitioners and pharmacists of the Ommoord district to the Rotterdam Study is gratefully acknowledged. The contributions to the Management Team specifcally and the Rotterdam Study at large of the following persons are pivotal to the daily operations of the study and highly appreciated: Jacobus Lubbe, Gabriëlle Bakker, Eric Neeleman, Jeannette Vergeer, Anneke Korving, Pauline van Wijngaarden, Jolande Verkroost – van Heemst, Silvan Licher, Isabel van